Characterization and complete genome sequence analysis of two Myoviral bacteriophages infecting clinical carbapenem-resistant Acinetobacter baumannii isolates

Journal of Applied Microbiology

Volumn 121, Issue 1, 2016, Pages 68-77

  Jeon, J ^a   D'Souza, R ^a   Pinto, N ^a   Ryu, C M ^b,c   Park, J ^d   Yong, D ^a   Lee, K ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c University of Science and Technology (UST)   (South Korea)

^d Chonnam National University   (South Korea)

Author keywords

Acinetobacter baumannii; antimicrobial alternatives; bacteriophage; biocontrol; carbapenem; Myoviridae

Indexed keywords

GENES; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; SEWAGE; SHELLFISH;

ACINETOBACTER BAUMANNII; ACINETOBACTERS; ANTIMICROBIAL ALTERNATIVE; BAUMANNII; CARBAPENEMS; COMPLETE GENOMES; GENOME SEQUENCES; IN-VITRO; MYOVIRIDA; SEQUENCE ANALYSIS;

BACTERIOPHAGES;

DOUBLE STRANDED DNA;

ANTIBIOTICS; ANTIMICROBIAL ACTIVITY; BACTERIOPHAGE; BACTERIUM; BIOCONTROL AGENT; CHEMICAL ANALYSIS; DNA; GENOME; HEALTH CARE; HOST; INFECTIVITY; MOLECULAR ANALYSIS; PHENOTYPE; SEWAGE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIOLYSIS; BACTERIOPHAGE; BACTERIUM ISOLATE; CARBAPENEM RESISTANT ACINETOBACTER BAUMANNII; CONTROLLED STUDY; GENOME ANALYSIS; HOST RANGE; MYOVIRAL BACTERIOPHAGE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PH; SEQUENCE ANALYSIS; SEWAGE; THERMOSTABILITY; TRANSMISSION ELECTRON MICROSCOPY; VIRUS CELL INTERACTION; VIRUS GENOME;

ACINETOBACTER BAUMANNII; BACTERIA (MICROORGANISMS); MYOVIRIDAE;

EID: 84976479137     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/jam.13134     Document Type: Article

References (32)

1. Abedon, S.T., Kuhl, S.J., Blasdel, B.G. and Kutter, E.M. (2011) Phage treatment of human infections. Bacteriophage 1, 66–85.
2. Alisky, J., Iczkowski, K., Rapoport, A. and Troitsky, N. (1998) Bacteriophages show promise as antimicrobial agents. J Infect 36, 5–15.
3. Besemer, J., Lomsadze, A. and Borodovsky, M. (2001) GeneMarkS: a self-training method for prediction of gene starts in microbial genomes. Implications for finding sequence motifs in regulatory regions. Nucleic Acids Res 29, 2607–2618.
4. Bruttin, A. and Brussow, H. (2005) Human volunteers receiving Escherichia coli phage T4 orally: a safety test of phage therapy. Antimicrob Agents Chemother 49, 2874–2878.
5. Burrowes, B., Harper, D.R., Anderson, J., McConville, M. and Enright, M.C. (2011) Bacteriophage therapy: potential uses in the control of antibiotic-resistant pathogens. Expert Rev Anti Infect Ther 9, 775–785.
6. Carver, T., Thomson, N., Bleasby, A., Berriman, M. and Parkhill, J. (2009) DNAPlotter: circular and linear interactive genome visualization. Bioinformatics 25, 119–120.
7. Chung, H.-S., Lee, Y., Park, E.S., Lee, D.S., Ha, E.J., Kim, M., Yong, D., Jeong, S.H. et al. (2014) Characterization of the multidrug-resistant Acinetobacter species causing a nosocomial outbreak at intensive care units in a Korean Teaching Hospital: suggesting the correlations with the clinical and environmental samples, including respiratory tract-related instruments. Ann Clin Microbiol 17, 29–34.
8. Dijkshoorn, L., Nemec, A. and Seifert, H. (2007) An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5, 939–951.
9. Frampton, R.A., Taylor, C., Holguin Moreno, A.V., Visnovsky, S.B., Petty, N.K., Pitman, A.R. and Fineran, P.C. (2014) Identification of bacteriophages for biocontrol of the kiwifruit canker phytopathogen Pseudomonas syringae pv. actinidiae. Appl Environ Microbiol 80, 2216–2228.
10. Higgins, P.G., Dammhayn, C., Hackel, M. and Seifert, H. (2010) Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 65, 233–238.
11. Hyman, P. and Abedon, S.T. (2009) Practical methods for determining phage growth parameters. Methods Mol Biol 501, 175–202.
12. Jin, J., Li, Z.J., Wang, S.W., Wang, S.M., Huang, D.H., Li, Y.H., Ma, Y.Y., Wang, J. et al. (2012) Isolation and characterization of ZZ1, a novel lytic phage that infects Acinetobacter baumannii clinical isolates. BMC Microbiol 12, 156.
13. Kropinski, A.M., Mazzocco, A., Waddell, T.E., Lingohr, E. and Johnson, R.P. (2009) Enumeration of bacteriophages by double agar overlay plaque assay. Methods Mol Biol 501, 69–76.
14. Kutateladze, M. and Adamia, R. (2010) Bacteriophages as potential new therapeutics to replace or supplement antibiotics. Trends Biotechnol 28, 591–595.
15. Lee, C.N., Tseng, T.T., Lin, J.W., Fu, Y.C., Weng, S.F. and Tseng, Y.H. (2011) Lytic myophage Abp53 encodes several proteins similar to those encoded by host Acinetobacter baumannii and phage phiKO2. Appl Environ Microbiol 77, 6755–6762.
16. Magiorakos, A.P., Srinivasan, A., Carey, R.B., Carmeli, Y., Falagas, M.E., Giske, C.G., Harbarth, S., Hindler, J.F. et al. (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18, 268–281.
17. Mahony, J., McAuliffe, O., Ross, R.P. and van Sinderen, D. (2011) Bacteriophages as biocontrol agents of food pathogens. Curr Opin Biotechnol 22, 157–163.
18. Merabishvili, M., Vandenheuvel, D., Kropinski, A.M., Mast, J., De Vos, D., Verbeken, G., Noben, J.P., Lavigne, R. et al. (2014) Characterization of newly isolated lytic bacteriophages active against Acinetobacter baumannii. PLoS ONE 9, e104853.
19. Munoz-Price, L.S. and Weinstein, R.A. (2008) Acinetobacter infection. N Engl J Med 358, 1271–1281.
20. Nordmann, P. and Poirel, L. (2002) Emerging carbapenemases in Gram-negative aerobes. Clin Microbiol Infect 8, 321–331.
21. O'Flaherty, S., Ross, R.P. and Coffey, A. (2009) Bacteriophage and their lysins for elimination of infectious bacteria. FEMS Microbiol Rev 33, 801–819.
22. Peng, F., Mi, Z., Huang, Y., Yuan, X., Niu, W., Wang, Y., Hua, Y., Fan, H. et al. (2014) Characterization, sequencing and comparative genomic analysis of vB_AbaM-IME-AB2, a novel lytic bacteriophage that infects multidrug-resistant Acinetobacter baumannii clinical isolates. BMC Microbiol 14, 181.
23. Perez, F., Hujer, A.M., Hujer, K.M., Decker, B.K., Rather, P.N. and Bonomo, R.A. (2007) Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 51, 3471–3484.
24. Plunkett, G. 3rd, Rose, D.J., Durfee, T.J. and Blattner, F.R. (1999) Sequence of Shiga toxin 2 phage 933W from Escherichia coli O157:H7: Shiga toxin as a phage late-gene product. J Bacteriol 181, 1767–1778.
25. Popova, A.V., Zhilenkov, E.L., Myakinina, V.P., Krasilnikova, V.M. and Volozhantsev, N.V. (2012) Isolation and characterization of wide host range lytic bacteriophage AP22 infecting Acinetobacter baumannii. FEMS Microbiol Lett 332, 40–46.
26. Saussereau, E. and Debarbieux, L. (2012) Bacteriophages in the experimental treatment of Pseudomonas aeruginosa infections in mice. Adv Virus Res 83, 123–141.
27. Sulakvelidze, A., Alavidze, Z. and Morris, J.G. Jr (2001) Bacteriophage therapy. Antimicrob Agents Chemother 45, 649–659.
28. Tiwari, B.R., Kim, S., Rahman, M. and Kim, J. (2011) Antibacterial efficacy of lytic Pseudomonas bacteriophage in normal and neutropenic mice models. J Microbiol 49, 994–999.
29. Wikler, M.A. and Clinical and Laboratory Standards, I. (2010) Antimicrobial Susceptibility Testing: Twentieth Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute.
30. Wilcox, S.A., Toder, R. and Foster, J.W. (1996) Rapid isolation of recombinant lambda phage DNA for use in fluorescence in situ hybridization. Chromosome Res 4, 397–398.
31. Wittebole, X., De Roock, S. and Opal, S.M. (2014) A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence 5, 226–235.
32. Yang, H., Liang, L., Lin, S. and Jia, S. (2010) Isolation and characterization of a virulent bacteriophage AB1 of Acinetobacter baumannii. BMC Microbiol 10, 131.